Team

Rohit Moudgil, MD, PhD, is a cardiologist in the Section of Clinical Cardiology, Tomsich Family Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute. He sees patients at Cleveland Clinic Main Campus. His special interests include onco-cardiology, heart failure, clinical cardiology, aging of the heart, and inflammation of the heart.

Dr. Larissa Nekhlyudov is Professor of Medicine at Harvard Medical School, practicing internist at the Brigham and Women’s Hospital and Clinical Director, Internal Medicine for Cancer Survivors at the Dana-Farber Cancer Institute. Over the past two decades, her efforts have focused on clinical care, research, and teaching, with the goal of improving the quality of care for cancer survivors.  Dr. Nekhlyudov is regarded as one of a handful of primary care providers at the forefront of the field of cancer survivorship, both nationally and internationally. Her publications (including original journal articles and editorials, book chapters and two books) as well as broad-ranging educational programs have promoted awareness among health care professionals about the ongoing needs of cancer patients across the care continuum. Throughout her career, Dr. Nekhlyudov has been dedicated to teaching and mentoring students, residents, fellows, and faculty, and has been committed to empowering cancer survivors and caregivers.

Sharon is the center manager and treating physical therapist at NovaCare’s Crestview Hills center where she oversees the day-to day operations of the facility and mentoring the staff in clinical and service excellence. She particularly enjoys working with knee, shoulder and TMJ patients as these conditions have the biggest impact on a person’s ability to function at the highest level. Sharon loves using an eclectic approach using the most efficient and effective means of treatment including exercises, dry needling and other manual techniques as she guides each patient to a successful recovery. Sharon received a bachelor’s degree from the University of Kentucky and master’s degree in physical therapy. Sharon is the Director of ReVital Cancer care for the Cincinnati-Dayton-NKY market. She is also a certified lymphedema specialist.

Dr. Zulfa Omer is an Assistant Professor of Medicine in the Division of Hematology and Medical Oncology at the University of Cincinnati and serves as the Disease Research Group Leader for Malignant Hematology at the UC Cancer Center. She completed her medical degree at the University of Khartoum, Sudan, and her Internal Medicine residency at Lincoln Medical Center and her Hematology/Oncology fellowship at the University of Cincinnati.

Dr. Omer’s research focuses on developing innovative early-phase clinical trials, with an emphasis on investigating small molecule inhibitors and T-cell therapies, aiming to improve outcomes and enhance the quality of life for CLL and lymphoma patients. She currently leads multiple investigator-initiated and industry clinical trials.

Thomas D. Ryan, MD, PhD, FAAP, FACC, FAHA is the Associate Director of the Advanced Cardiomyopathy Program, Director of the Cardio-Oncology Program at Cincinnati Children’s Hospital Medical Center (CCHMC), and Professor of Pediatrics-Clinical at the University of Cincinnati College of Medicine.

Dr. Ryan earned both an MD and PhD at the University of Alabama School of Medicine/University of Alabama at Birmingham. He completed general pediatrics residency and pediatric cardiology fellowship at CCHMC and was the first graduate of the CCHMC Heart Institute’s Advanced Fellowship in Pediatric Heart Failure, Cardiomyopathy, and Cardiac Transplantation.

Dr. Ryan’s clinical and research interests focus on inherited and acquired cardiomyopathy as well as cardiac transplantation. He has published over 95 manuscripts in peer-reviewed journals and is author of more than 10 textbook chapters. He was on the founding Leadership Council for the Cardio-Oncology Member Section of the American College of Cardiology and was the first Chair of the Pediatric Working Group and is co-founder of the Pediatric Cardio-Oncology Consortium. Dr. Ryan serves as Co-Chair of the Institutional Review Board at CCHMC, as well as Section Editor for the journal Cardio-Oncology and Associate Editor for the journal Progress in Pediatric Cardiology.

Dr. Erin Scott is an associate professor in the Palliative Medicine Division of the Department of Internal Medicine at The Ohio State University. As an outpatient palliative care physician, she manages symptoms and cancer-related stress for individuals diagnosed with solid-tumor and hematologic malignancies. Dr. Scott serves as Program Director for the Hospice and Palliative Medicine fellowship and the Co-Program Director the Medical Oncology/Hospice and Palliative Medicine fellowship at OSU. Dr. Scott’s clinical interests are focused on providing high quality care and symptom management for patients and their loved ones who are facing a serious illness.

Dr. Elizabeth (Beth) Shaughnessy hails from the Chicago Metropolitan area.  She obtained her BS at the University of Illinois at Urbana-Champaign In Honors Biology before completing medical school at the University of Illinois at Chicago. She completed her residency in general surgery in Chicago before her fellowship in surgical oncology at the City of Hope Comprehensive Cancer Center in California.  There, she was introduced to the concept of cancer survivorship, which intrigued her. She brought that interest with her to the University of Cincinnati where she helped in the early formation of Cancer Survivorship.  Later, as a cancer survivor, she joined forces to assume administrative responsibilities and grow educational and research programs.

Dr. Sophia Smith is an Associate Professor with Tenure at the Duke School of Nursing and earned her PhD and MSW degrees at UNC-Chapel Hill School of Social Work. Her research explores ways to improve the quality of cancer care including post-treatment survivorship and palliative care with a primary focus on leveraging technology in delivering behavioral health interventions to the community. She is leading efforts to integrate clinical cancer care and research in building the scientific evidence that informs evidence-based practice through her current and past membership on the National Comprehensive Cancer Network (NCCN) Survivorship Guidelines Panel and American Society of Clinical Oncology (ASCO) Survivorship Committee. Dr. Smith’s research has been funded by the National Institutes of Health, the American Cancer Society, NCCN, and Pfizer Grants for Independent Learning and Change.